Cargando…
Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines
Mitochondria have emerged as a prospective target to overcome drug resistance that limits triple-negative breast cancer therapy. A novel mitochondria-targeted compound, HO-5114, demonstrated higher cytotoxicity against human breast cancer lines than its component-derivative, Mito-CP. In this study,...
Autores principales: | Andreidesz, Kitti, Szabo, Aliz, Kovacs, Dominika, Koszegi, Balazs, Bagone Vantus, Viola, Vamos, Eszter, Isbera, Mostafa, Kalai, Tamas, Bognar, Zita, Kovacs, Krisztina, Gallyas, Ferenc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396499/ https://www.ncbi.nlm.nih.gov/pubmed/34445722 http://dx.doi.org/10.3390/ijms22169016 |
Ejemplares similares
-
Effect of Oxaliplatin, Olaparib and LY294002 in Combination on Triple-Negative Breast Cancer Cells
por: Andreidesz, Kitti, et al.
Publicado: (2021) -
Syntheses and Study of a Pyrroline Nitroxide Condensed Phospholene Oxide and a Pyrroline Nitroxide Attached Diphenylphosphine
por: Isbera, Mostafa, et al.
Publicado: (2021) -
Syntheses and Reactions of Pyrroline, Piperidine Nitroxide Phosphonates
por: Isbera, Mostafa, et al.
Publicado: (2020) -
Involvement of Mitochondrial Mechanisms in the Cytostatic Effect of Desethylamiodarone in B16F10 Melanoma Cells
por: Ramadan, Fadi H. J., et al.
Publicado: (2020) -
Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn's Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells
por: Kovács, Dominika, et al.
Publicado: (2021)